Daniel B Mark1, Kevin J Anstrom2, Shubin Sheng2, Khaula N Baloch2, Melanie R Daniels2, Udo Hoffmann2, Manesh R Patel2, Lawton S Cooper2, Kerry L Lee2, Pamela S Douglas2. 1. From Outcomes Research Group (D.B.M., K.J.A., S.S., K.N.B., M.R.D.), Duke Clinical Research Institute (D.B.M., K.J.A., S.S., K.N.B., M.R.D., M.R.P., K.L.L., P.S.D.), Duke University Medical Center, Durham, NC; Massachusetts General Hospital, Harvard Medical School, Boston (U.H.); and National Heart, Lung, and Blood Institute, Bethesda, MD (L.S.C.). daniel.mark@duke.edu. 2. From Outcomes Research Group (D.B.M., K.J.A., S.S., K.N.B., M.R.D.), Duke Clinical Research Institute (D.B.M., K.J.A., S.S., K.N.B., M.R.D., M.R.P., K.L.L., P.S.D.), Duke University Medical Center, Durham, NC; Massachusetts General Hospital, Harvard Medical School, Boston (U.H.); and National Heart, Lung, and Blood Institute, Bethesda, MD (L.S.C.).
Abstract
BACKGROUND: The Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial found that initial use of ≥64 detector-row computed tomography angiography versus standard functional testing strategies (exercise ECG, stress nuclear methods, or stress echocardiography) did not improve clinical outcomes in 10 003 stable symptomatic patients with suspected coronary artery disease requiring noninvasive testing. Symptom burden and quality of life (QOL) were major secondary outcomes. METHODS AND RESULTS: We prospectively collected a battery of QOL instruments in 5985 patients at baseline and 6, 12, and 24 months postrandomization. The prespecified primary QOL measures were the Duke Activity Status Index and the Seattle Angina Questionnaire frequency and QOL scales. All comparisons were made as randomized. Baseline variables were well balanced in the 2982 patients randomly assigned tocomputed tomography angiography testing and the 3003 patients randomly assigned to functional testing. The Duke Activity Status Index improved substantially in both groups over the first 6 months following testing, but we found no evidence for a strategy-related difference (mean difference [anatomic - functional] at 24 months of follow-up, 0.1 [95% confidence interval, -0.9 to 1.1]). Similar results were seen for the Seattle Angina Questionnaire frequency scale (mean difference at 24 months, -0.2; 95% confidence interval, -0.8 to 0.4) and QOL scale (mean difference at 24 months, -0.2; 95% confidence interval, -1.3 to 0.9). None of the secondary QOL measures showed a consistent strategy-related difference. CONCLUSIONS: In symptomatic patients with suspected coronary artery disease who required noninvasive testing, symptoms and QOL improved significantly. However, a strategy of initial anatomic testing, in comparison with functional testing, did not provide an incremental benefit for QOL over 2 years of follow-up. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT01174550.
RCT Entities:
BACKGROUND: The Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial found that initial use of ≥64 detector-row computed tomography angiography versus standard functional testing strategies (exercise ECG, stress nuclear methods, or stress echocardiography) did not improve clinical outcomes in 10 003 stable symptomatic patients with suspected coronary artery disease requiring noninvasive testing. Symptom burden and quality of life (QOL) were major secondary outcomes. METHODS AND RESULTS: We prospectively collected a battery of QOL instruments in 5985 patients at baseline and 6, 12, and 24 months postrandomization. The prespecified primary QOL measures were the Duke Activity Status Index and the Seattle Angina Questionnaire frequency and QOL scales. All comparisons were made as randomized. Baseline variables were well balanced in the 2982 patients randomly assigned to computed tomography angiography testing and the 3003 patients randomly assigned to functional testing. The Duke Activity Status Index improved substantially in both groups over the first 6 months following testing, but we found no evidence for a strategy-related difference (mean difference [anatomic - functional] at 24 months of follow-up, 0.1 [95% confidence interval, -0.9 to 1.1]). Similar results were seen for the Seattle Angina Questionnaire frequency scale (mean difference at 24 months, -0.2; 95% confidence interval, -0.8 to 0.4) and QOL scale (mean difference at 24 months, -0.2; 95% confidence interval, -1.3 to 0.9). None of the secondary QOL measures showed a consistent strategy-related difference. CONCLUSIONS: In symptomatic patients with suspected coronary artery disease who required noninvasive testing, symptoms and QOL improved significantly. However, a strategy of initial anatomic testing, in comparison with functional testing, did not provide an incremental benefit for QOL over 2 years of follow-up. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT01174550.
Authors: Daniel B Mark; Leslee J Shaw; Michael S Lauer; Patrick G O'Malley; Paul Heidenreich Journal: J Am Coll Cardiol Date: 2003-06-04 Impact factor: 24.094
Authors: M A Hlatky; R E Boineau; M B Higginbotham; K L Lee; D B Mark; R M Califf; F R Cobb; D B Pryor Journal: Am J Cardiol Date: 1989-09-15 Impact factor: 2.778
Authors: Mark A Hlatky; Bernard De Bruyne; Gianluca Pontone; Manesh R Patel; Bjarne L Norgaard; Robert A Byrne; Nick Curzen; Ian Purcell; Matthias Gutberlet; Gilles Rioufol; Ulrich Hink; Herwig Walter Schuchlenz; Gudrun Feuchtner; Martine Gilard; Daniele Andreini; Jesper M Jensen; Martin Hadamitzky; Alan Wilk; Furong Wang; Campbell Rogers; Pamela S Douglas Journal: J Am Coll Cardiol Date: 2015-10-14 Impact factor: 24.094
Authors: M A Hlatky; W J Rogers; I Johnstone; D Boothroyd; M M Brooks; B Pitt; G Reeder; T Ryan; H Smith; P Whitlow; R Wiens; D B Mark Journal: N Engl J Med Date: 1997-01-09 Impact factor: 91.245
Authors: James K Min; Ning Kang; Leslee J Shaw; Richard B Devereux; Matthew Robinson; Fay Lin; Antonio P Legorreta; Amanda Gilmore Journal: Radiology Date: 2008-10 Impact factor: 11.105
Authors: J A Spertus; J A Winder; T A Dewhurst; R A Deyo; J Prodzinski; M McDonell; S D Fihn Journal: J Am Coll Cardiol Date: 1995-02 Impact factor: 24.094
Authors: Gianluca Pontone; Alexia Rossi; Marco Guglielmo; Marc R Dweck; Oliver Gaemperli; Koen Nieman; Francesca Pugliese; Pal Maurovich-Horvat; Alessia Gimelli; Bernard Cosyns; Stephan Achenbach Journal: Eur Heart J Cardiovasc Imaging Date: 2022-02-22 Impact factor: 6.875
Authors: Daniel B Mark; John A Spertus; Robert Bigelow; Sophia Anderson; Melanie R Daniels; Kevin J Anstrom; Khaula N Baloch; David J Cohen; Claes Held; Shaun G Goodman; Sripal Bangalore; Derek Cyr; Harmony R Reynolds; Karen P Alexander; Yves Rosenberg; Gregg W Stone; David J Maron; Judith S Hochman Journal: Circulation Date: 2022-03-09 Impact factor: 39.918
Authors: Patricia A Ganz; Edward H Romond; Reena S Cecchini; Priya Rastogi; Charles E Geyer; Sandra M Swain; Jong-Hyeon Jeong; Louis Fehrenbacher; Howard M Gross; Adam M Brufsky; Patrick J Flynn; Tanya A Wahl; Thomas E Seay; James L Wade; David D Biggs; James N Atkins; Jonathan Polikoff; John L Zapas; Eleftherios P Mamounas; Norman Wolmark Journal: J Clin Oncol Date: 2017-10-26 Impact factor: 44.544
Authors: Leslee J Shaw; Ron Blankstein; Jill E Jacobs; Jonathon A Leipsic; Raymond Y Kwong; Viviany R Taqueti; Rob S B Beanlands; Jennifer H Mieres; Scott D Flamm; Thomas C Gerber; John Spertus; Marcelo F Di Carli Journal: Circ Cardiovasc Imaging Date: 2017-12 Impact factor: 7.792
Authors: Valentina Lorenzoni; Stefania Bellelli; Chiara Caselli; Juhani Knuuti; Stephen Richard Underwood; Danilo Neglia; Giuseppe Turchetti Journal: Eur J Health Econ Date: 2019-08-13
Authors: Nina Rieckmann; Konrad Neumann; Sarah Feger; Paolo Ibes; Adriane Napp; Daniel Preuß; Henryk Dreger; Gudrun Feuchtner; Fabian Plank; Vojtěch Suchánek; Josef Veselka; Thomas Engstrøm; Klaus F Kofoed; Stephen Schröder; Thomas Zelesny; Matthias Gutberlet; Michael Woinke; Pál Maurovich-Horvat; Béla Merkely; Patrick Donnelly; Peter Ball; Jonathan D Dodd; Mark Hensey; Bruno Loi; Luca Saba; Marco Francone; Massimo Mancone; Marina Berzina; Andrejs Erglis; Audrone Vaitiekiene; Laura Zajanckauskiene; Tomasz Harań; Malgorzata Ilnicka Suckiel; Rita Faria; Vasco Gama-Ribeiro; Imre Benedek; Ioana Rodean; Filip Adjić; Nada Čemerlić Adjić; José Rodriguez-Palomares; Bruno Garcia Del Blanco; Katriona Brooksbank; Damien Collison; Gershan Davis; Erica Thwaite; Juhani Knuuti; Antti Saraste; Cezary Kępka; Mariusz Kruk; Theodora Benedek; Mihaela Ratiu; Aleksandar N Neskovic; Radosav Vidakovic; Ignacio Diez; Iñigo Lecumberri; Michael Fisher; Balazs Ruzsics; William Hollingworth; Iñaki Gutiérrez-Ibarluzea; Marc Dewey; Jacqueline Müller-Nordhorn Journal: Health Qual Life Outcomes Date: 2020-05-14 Impact factor: 3.186